Influential Businesswoman Awards 2026 | 33 Pharmaceutical Businesswoman of the Year 2026 (UK): Karen Pulley Since its inception in 2005, Consilient Health has focused on the commercialisation of niche and generic medicines. The organisation’s work spans the full commercial lifecycle, from product selection and market access through to stakeholder engagement and ongoing support for healthcare systems. It works closely with healthcare professionals, the NHS, and industry partners to ensure patients are provided with access to high-quality, affordable treatments. In recent years, Consilient Health has strengthened its focus on responsible business practices, embedding sustainability, wellbeing, and ethical governance into its strategy. This move reflected a broader commitment for the organisation, not only to achieving commercial success but also to delivering long-term value for patients, partners, and wider society. It is a mission headed by Karen Pulley, Head of Sustainability. Karen Pulley has been with Consilient Health for over 15 years, holding her current role since 2020. She is responsible for developing and delivering the company’s sustainability strategy, working closely with the executive team to align environmental, social, and governance priorities with business objectives. Karen’s role includes establishing the carbon footprint baseline, embedding ESG criteria into supplier selection, and driving initiatives across areas such as workplace wellbeing, responsible sourcing, and community engagement. Over the course of her career, Karen believes one of her most significant achievements to have been establishing and implementing the sustainability strategy at Consilient Health. She built the strategy from the ground up, gaining board-level approval and budget, and translated it into practical initiatives across the business. This required engaging colleagues at all levels, aligning sustainability with commercial priorities, and creating a framework that is both measurable and meaningful. This was made possible by extensive experience. “My career path has been intentionally broad,” she told us. “I began in operational and administrative roles, before moving into sales, training, stakeholder engagement, and leadership positions across the pharmaceutical sector. This has given me a strong understanding of both the commercial and people aspects of the business. Prior to my current role, I led national training and professional relationship programmes, which involved strategic planning, stakeholder mapping, and cross-functional collaboration. “That combination of commercial experience, people development, and strategic thinking has been instrumental in enabling me to lead sustainability as a business-wide transformation rather than a standalone initiative.” The pharmaceutical industry faces increasing sustainability demands, compounded by a complex system of stakeholders, including consumers, employers, shareholders, regulators, medical doctors, and insurers. Improving environmental impact is a key priority for pharmaceutical Consilient Health is a medium-sized pharmaceutical company operating across the UK, Ireland, and the Nordics. The organisation is driven by a dedication to operating responsibly, with sustainability deeply embedded into the core of its business strategy. This is led by Head of Sustainability Karen Pulley, who has been recently recognised for in the Influential Businesswoman Awards 2026 for her work in the field. We heard more from Karen below. Consilient Health companies around the world, particularly as regulations continue to reshape the global sector. The ESG framework has become an invaluable asset to such companies, as the current most widely accepted framework to investigate an organisation’s sustainability impact. Consilient Health successfully leads the charge in sustainable practices under Karen’s expert leadership, embedding essential ESG principles into every aspect of its operations. The Head of Sustainability works externally with partners, universities, and industry groups and sits as Chair of the Sustainability Working Group for Medicines UK, as well as taking an active role in the Ethical Medicines Industry Group and sitting on Medicines for Europe Sustainability Committee. Karen has made significant strides in her time with Consilient Health, truly earning her status as the UK’s Pharmaceuticals Businesswoman of the Year 2026. “I am particularly proud of the cultural impact of the work,” she reflected, “introducing wellbeing programmes, achieving external recognition such as Gold CSR Accreditation, and building partnerships that extend beyond the organisation. For me, success has been about not only delivering a strategy, but embedding a mindset that sustainability is part of how we do business every day.” The future of Consilient Health will centre on sustainable growth, both commercially and environmentally. Karen will focus on strengthening and evolving the organisation’s sustainability agenda, ensuring it remains aligned with both business strategy and external expectations. This will include deepening supplier engagement, improving data quality across Scope 3 emissions, and embedding sustainability further into the decision-making process. She shared: “As the pharmaceutical industry evolves, companies that can balance commercial success with responsible practices will be best positioned for long-term success.” Contact: Karen Pulley Company: Consilient Health Web Address: www.consilienthealth.com
RkJQdWJsaXNoZXIy MTUyMDQwMA==